Skip to main content
. 2015 Nov 27;5:17640. doi: 10.1038/srep17640

Figure 6. Antigene activity of R9-PNAs targeting HBV DNA in different cell lines for 3 days.

Figure 6

HepG2.2.15 cells integrated with HBV DNA in the chromosome (a), HepG2 cells transfected with the pUC18-HBV1.2 plasmid (b), and HepDES19 cells containing episomal HBV cccDNA (c) were treated with 1 μM antigene or antisense R9-PNAs with or without chloroquine (CQ).